Purification and characterization of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation.
Tissue-type plasminogen activator (TPA) was purified from maxillary mucosa with chronic inflammation and compared with urokinase. Purification procedure consisted of the extraction from delipidated mucosa with 0.3M potassium acetate buffer (pH 4.2), 66% saturation of ammonium sulfate, zinc chelate-Sepharose, concanavalin A-Sepharose and Sephadex G-100 gel filtration chromatographies. The molecular weight of the TPA was approximately 58,000 +/- 3,000. Its activity was enhanced in the presence of fibrin and was quenched by placental urokinase inhibitor, but not quenched by anti-urokinase antibody. The TPA made no precipitin line against anti-urokinase antibody, while urokinase did. All these findings indicate that the TPA in maxillary mucosa with chronic inflammation is immunologically dissimilar to urokinase and in its affinity for fibrin.
D000328:Adult; D002850:Chromatography, Gel; D002908:Chronic Disease; D004355:Drug Stability; D005260:Female; D006801:Humans; D005779:Immunodiffusion; D008297:Male; D008443:Maxillary Sinus; D009297:Nasal Mucosa / Q000201:enzymology*; D010926:Placental Hormones / Q000494:pharmacology; D012852:Sinusitis / Q000201:enzymology*; D010959:Tissue Plasminogen Activator / Q000037:antagonists & inhibitors / Q000302:isolation & purification* / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors
D010926:Placental Hormones; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator